Jan Stankiewicz

454 total citations
8 papers, 356 citations indexed

About

Jan Stankiewicz is a scholar working on Neurology, Oncology and Genetics. According to data from OpenAlex, Jan Stankiewicz has authored 8 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Neurology, 3 papers in Oncology and 2 papers in Genetics. Recurrent topics in Jan Stankiewicz's work include Parkinson's Disease Mechanisms and Treatments (4 papers), Drug Transport and Resistance Mechanisms (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). Jan Stankiewicz is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (4 papers), Drug Transport and Resistance Mechanisms (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). Jan Stankiewicz collaborates with scholars based in Poland, United States and United Kingdom. Jan Stankiewicz's co-authors include Krystyna Honczarenko, Z Sych, Marek Droździk, Monika Białecka, B Gawrońska-Szklarz, Gabriela Kłodowska-Duda, Grzegorz Opala, E Dabrowska, Przemysław Nowacki and Teresa Wierzba‐Bobrowicz and has published in prestigious journals such as European Journal of Clinical Pharmacology, Acta Neurologica Scandinavica and European Neurology.

In The Last Decade

Jan Stankiewicz

8 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan Stankiewicz Poland	6	187	128	114	61	49	8	356
Nian Yu China	12	78 0.4×	122 1.0×	48 0.4×	72 1.2×	108 2.2×	27	380
Anna Jeong United States	12	34 0.2×	38 0.3×	112 1.0×	60 1.0×	58 1.2×	22	346
Qing Di China	12	78 0.4×	121 0.9×	18 0.2×	76 1.2×	106 2.2×	20	357
Min‐Jee Kim South Korea	10	36 0.2×	40 0.3×	24 0.2×	78 1.3×	19 0.4×	43	308
Cécile Lecointe France	8	23 0.1×	44 0.3×	22 0.2×	81 1.3×	74 1.5×	9	320
Jinze Wu China	9	26 0.1×	13 0.1×	69 0.6×	104 1.7×	40 0.8×	12	310
Mark C. Hwang United States	10	44 0.2×	13 0.1×	12 0.1×	84 1.4×	47 1.0×	31	391
Sandra Sabbagh Lebanon	11	26 0.1×	153 1.2×	9 0.1×	118 1.9×	44 0.9×	30	369
Kurt Schlachter Austria	8	14 0.1×	121 0.9×	59 0.5×	77 1.3×	79 1.6×	12	346
Tomohiro Kumada Japan	13	11 0.1×	51 0.4×	22 0.2×	168 2.8×	36 0.7×	44	398

Countries citing papers authored by Jan Stankiewicz

Since Specialization

Citations

This map shows the geographic impact of Jan Stankiewicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Stankiewicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Stankiewicz more than expected).

Fields of papers citing papers by Jan Stankiewicz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Stankiewicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Stankiewicz. The network helps show where Jan Stankiewicz may publish in the future.

Co-authorship network of co-authors of Jan Stankiewicz

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Stankiewicz. A scholar is included among the top collaborators of Jan Stankiewicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Stankiewicz. Jan Stankiewicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Honczarenko, Krystyna, et al.. (2010). Usefulness of the ALSAQ-5 scale in evaluation of quality of life in amyotrophic lateral sclerosis. Neurologia i Neurochirurgia Polska. 44(6). 560–566. 5 indexed citations

2.

Białecka, Monika, Marek Droździk, Krystyna Honczarenko, et al.. (2005). Catechol-O-Methyltransferase and Monoamine Oxidase B Genes and Susceptibility to Sporadic Parkinson’s Disease in a Polish Population. European Neurology. 53(2). 68–73. 17 indexed citations

3.

Białecka, Monika, Marek Droździk, Gabriela Kłodowska-Duda, et al.. (2004). The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease. Acta Neurologica Scandinavica. 110(4). 260–266. 59 indexed citations

4.

Droździk, Marek, et al.. (2003). Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease.. PubMed. 13(5). 259–63. 147 indexed citations

5.

Honczarenko, Krystyna, et al.. (2003). Polymorphism in the P-glycoprotein drug transporter MDR1 gene. Pharmacogenetics. 13(5). 259–263. 112 indexed citations

6.

Nowacki, Przemysław, et al.. (2003). Extreme loss of neurons in sporadic Creutzfeldt-Jakob disease with 14-3-3 protein in cerebrospinal fluid.. PubMed. 41(1). 47–50. 1 indexed citations

7.

Białecka, Monika, B Gawrońska-Szklarz, Marek Droździk, Krystyna Honczarenko, & Jan Stankiewicz. (2002). N-acetyltransferase 2 polymorphism in sporadic Parkinson's disease in a Polish population. European Journal of Clinical Pharmacology. 57(12). 857–862. 13 indexed citations

8.

Nowacki, Przemysław, et al.. (1993). [Neurologic complications in high-grade non-Hodgkin's lymphomas. Clinico-neuropathological correlations].. PubMed. 26(3). 334–42. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact